Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan A. Bernstein, M.D.
UC Physicians, Division of Immunology
Principal Investigator - Joseph Moellman, MD
UC Physicians, Department of Emergency Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Jewish Hospital
Cincinnati, Ohio, United States
Joseph Moellman, MDRecruiting - Uc Physicians, Dpt of Internal Medicine, Division of Immunology
Cincinnati, Ohio, United States
Recruiting - Univeristy Hospital
Cincinnati, Ohio, United States
Jonathan A Bernstein, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2010
- Primary completion
- 30 Jun 2013
- Completion
- 31 Dec 2013
- Last update posted
- 9 Mar 2012
- Registered enrollment
- 50
- Registry id
- NCT01036659
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.